KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Receivables (2017 - 2025)

Historic Receivables for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $975.0 million.

  • Elanco Animal Health's Receivables rose 785.4% to $975.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $975.0 million, marking a year-over-year increase of 785.4%. This contributed to the annual value of $886.0 million for FY2024, which is 1227.72% down from last year.
  • Elanco Animal Health's Receivables amounted to $975.0 million in Q3 2025, which was up 785.4% from $1.1 billion recorded in Q2 2025.
  • Elanco Animal Health's 5-year Receivables high stood at $1.3 billion for Q1 2023, and its period low was $886.0 million during Q4 2024.
  • In the last 5 years, Elanco Animal Health's Receivables had a median value of $1.1 billion in 2024 and averaged $1.1 billion.
  • Per our database at Business Quant, Elanco Animal Health's Receivables surged by 9033.72% in 2021 and then crashed by 2035.24% in 2024.
  • Over the past 5 years, Elanco Animal Health's Receivables (Quarter) stood at $1.0 billion in 2021, then decreased by 2.53% to $1.0 billion in 2022, then grew by 0.8% to $1.0 billion in 2023, then decreased by 12.28% to $886.0 million in 2024, then grew by 10.05% to $975.0 million in 2025.
  • Its Receivables stands at $975.0 million for Q3 2025, versus $1.1 billion for Q2 2025 and $1.1 billion for Q1 2025.